Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

348
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
348
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.4K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.4K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

2.7K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.7K
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

4.3K
Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
4.3K
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

665
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
665
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

381
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
381

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucocorticoid-prescribing trends in congenital adrenal hyperplasia, 2017 to 2023.

Endocrine connections·2026
Same author

Enhancing transition care for adolescents and young adults with adrenal insufficiency in the Netherlands: a holistic model for improved patient outcomes.

Endocrine connections·2025
Same author

Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey.

Endocrine connections·2024
Same author

Electronic reporting of rare endocrine conditions within a clinical network: results from the EuRRECa project.

Endocrine connections·2023
Same author

The current landscape of European registries for rare endocrine conditions.

European journal of endocrinology·2018
Same author

[Correction to: Endocrine paraneoplastic syndromes].

Der Internist·2018

Related Experiment Video

Updated: Dec 21, 2025

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

1.8K

[Modified-release hydrocortisone for glucocorticoid deficiency].

H Nowotny1, N Reisch2

  • 1Medizinische Klinik IV, Klinikum der Universität München, Ziemssenstraße 1, 80336, München, Deutschland.

Der Internist
|May 13, 2020
PubMed
Summary
This summary is machine-generated.

Modified-release hydrocortisone may benefit elderly patients by improving metabolism, cardiovascular health, immunity, and sleep compared to conventional therapy. This approach addresses risks associated with unphysiological glucocorticoid dosing.

Keywords:
Adrenal insufficiencyAgedCircadian clocksCircadian rhythmModified-release preparations

More Related Videos

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

10.0K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

5.1K

Related Experiment Videos

Last Updated: Dec 21, 2025

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

1.8K
Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

10.0K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

5.1K

Area of Science:

  • Endocrinology
  • Chronobiology
  • Geriatric Medicine

Background:

  • The suprachiasmatic nucleus and hypothalamus-pituitary-adrenal axis regulate circadian cortisol levels.
  • Unphysiological glucocorticoid doses increase morbidity, mortality, and reduce quality of life.

Purpose of the Study:

  • To evaluate the benefits of modified-release hydrocortisone versus conventional therapy in multimorbid elderly patients.

Main Methods:

  • Analysis of statistics, recent research, and expert advice.
  • Discussion of treatment outcomes and patient benefits.

Main Results:

  • Modified-release hydrocortisone (Plenadren®) improved body weight, BMI, and HbA1c compared to conventional therapy.
  • Conventional therapy increased risks of obesity, hypertension, hyperglycemia, cardiac events, and respiratory infections.
  • Conventional therapy reduced natural killer cell activity and cytotoxicity.

Conclusions:

  • Novel modified-release hydrocortisone offers metabolic, cardiovascular, immune, and sleep benefits.
  • These benefits are particularly relevant for multimorbid elderly patients.
  • This formulation may mitigate risks associated with unphysiological cortisol administration.